Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-39.37%
operating margin TTM
-41.43%
revenue TTM
69.93 Million
revenue per share TTM
0.72$
valuation ratios | |
|---|---|
| pe ratio | -15.54 |
| peg ratio | -0.33 |
| price to book ratio | 10.58 |
| price to sales ratio | 6.14 |
| enterprise value multiple | -19.34 |
| price fair value | 10.58 |
profitability ratios | |
|---|---|
| gross profit margin | 95.42% |
| operating profit margin | -41.43% |
| pretax profit margin | -40.25% |
| net profit margin | -39.37% |
| return on assets | -20.23% |
| return on equity | -70.65% |
| return on capital employed | -29.03% |
liquidity ratio | |
|---|---|
| current ratio | 3.20 |
| quick ratio | 3.20 |
| cash ratio | 0.63 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 35.69 |
| days of payables outstanding | 274.71 |
| cash conversion cycle | -239.03 |
| receivables turnover | 10.23 |
| payables turnover | 1.33 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.28 |
| debt equity ratio | 0.95 |
| long term debt to capitalization | 0.40 |
| total debt to capitalization | 0.49 |
| interest coverage | -6.89 |
| cash flow to debt ratio | -0.18 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.18 |
| cash per share | 2.38 |
| operating cash flow per share | -0.15 |
| free cash flow operating cash flow ratio | 1.14 |
| cash flow coverage ratios | -0.18 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -7.14 |
Frequently Asked Questions
When was the last time Poseida Therapeutics, Inc. (NASDAQ:PSTX) reported earnings?
Poseida Therapeutics, Inc. (PSTX) published its most recent earnings results on 07-11-2024.
What is Poseida Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Poseida Therapeutics, Inc. (NASDAQ:PSTX)'s trailing twelve months ROE is -70.65%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Poseida Therapeutics, Inc. (PSTX) currently has a ROA of -20.23%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PSTX's net profit margin stand at?
PSTX reported a profit margin of -39.37% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PSTX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.20 in the most recent quarter. The quick ratio stood at 3.20, with a Debt/Eq ratio of 0.95.